Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Berg

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and analogues in nonhuman primatesL Long, S L Berg, S K Roy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusionW H Wilson, S L Berg, G Bryant, et al.
Biochemical Pharmacology|June 28, 1996
Cytotoxicity and DNA damage associated with pyrazoloacridine in MCF-7 breast cancer cellsJ L Grem, P M Politi, S L Berg, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Thioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8-hydroxy-thioguanineB J Kitchen, A Moser, E Lowe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trialS M Blaney, N L Seibel, M O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factorD M Savarese, A M Denicoff, S L Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicinL H Wexler, M P Andrich, D Venzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group StudyS M Blaney, M N Needle, A Gillespie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancerA W Tolcher, K H Cowan, D Solomon, et al.
Cancer|August 1, 1996
Phase II evaluation of topotecan for pediatric central nervous system tumorsS M Blaney, P C Phillips, R J Packer, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Plasma and cerebrospinal fluid pharmacokinetics of O6-benzylguanine and analogues in nonhuman primatesL Long, S L Berg, S K Roy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusionW H Wilson, S L Berg, G Bryant, et al.
Biochemical Pharmacology|June 28, 1996
Cytotoxicity and DNA damage associated with pyrazoloacridine in MCF-7 breast cancer cellsJ L Grem, P M Politi, S L Berg, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Thioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8-hydroxy-thioguanineB J Kitchen, A Moser, E Lowe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trialS M Blaney, N L Seibel, M O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factorD M Savarese, A M Denicoff, S L Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicinL H Wexler, M P Andrich, D Venzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group StudyS M Blaney, M N Needle, A Gillespie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Phase I crossover study of paclitaxel with r-verapamil in patients with metastatic breast cancerA W Tolcher, K H Cowan, D Solomon, et al.
Cancer|August 1, 1996
Phase II evaluation of topotecan for pediatric central nervous system tumorsS M Blaney, P C Phillips, R J Packer, et al.
Pageof 4